Chronic treatment with 17β-estradiol increases susceptibility of smooth muscle cells to nitric oxide

European Journal of Pharmacology

Volumn 520, Issue 1-3, 2005, Pages 142-149

  Egami, Rika ^a   Tanaka, Yoshihiro ^a   Nozaki, Masahiro ^a   Koera, Keiko ^a   Okuma, Akiko ^a   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

17 Estradiol; Estrogen; Vascular smooth muscle

Indexed keywords

4 METHYL 2 (HYDROXIMINO) 5 NITRO 6 METHOXY 3 HEXENAMIDE; 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; BUCLADESINE; CARBACHOL; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; ESTRADIOL VALERATE; N ACETYL S NITROSOPENICILLAMINE; NICARDIPINE; NITRIC OXIDE; POTASSIUM ION; UNCLASSIFIED DRUG; VASODILATOR AGENT; ESTRADIOL; METHYL 2 HYDROXYIMINO 5 NITRO 6 METHOXY 3 HEXENEAMIDE; METHYL-2-HYDROXYIMINO-5-NITRO-6-METHOXY-3-HEXENEAMIDE; NITRO DERIVATIVE; POTASSIUM; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ESTROGEN THERAPY; EXPERIMENT; FEMALE; LONG TERM EXPOSURE; MEMBRANE PERMEABILITY; NONHUMAN; OVARIECTOMY; PHARMACODYNAMICS; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD; BODY WEIGHT; DOSE RESPONSE; METABOLISM; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; BASILAR ARTERY; BODY WEIGHT; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRO COMPOUNDS; OVARIECTOMY; POTASSIUM; RABBITS; S-NITROSO-N-ACETYLPENICILLAMINE; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 25444460907     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.07.028     Document Type: Article

References (56)

1. V. Abudara, C. Eyzaguirre, and J.C. Saez Short- and long-term regulation of rat carotid body gap junctions by cAMP. Identification of connexin43, a gap junction subunit Adv. Exp. Med. Biol. 75 2000 359 369
2. M.A. Barbacanne, J. Rami, J.B. Michel, J.P. Souchard, M. Philippe, J.P. Besombes, F. Bayard, and J.F. Arnal Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production Cardiovasc. Res. 41 1999 672 681
3. F. Bayard Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production Proc. Natl. Acad. Sci. U. S. A. 93 1996 4108 4113
4. M. Bei, M.C. Lavigne, M.L. Foegh, P.W. Ramwell, and R. Clarke Specific binding of estradiol to rat coronary artery smooth muscle cells J. Steroid Biochem. Mol. Biol. 58 1996 83 88
5. J. Binko, and H. Majewski 17 beta-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS Am. J. Physiol. Heart Circ. Physiol. 274 1998 H853 H859
6. J. Binko, T.V. Murphy, and H. Majewski 17 beta-oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta Clin. Exp. Pharmacol. Physiol. 25 1998 120 127
7. R.C. Burghardt, R. Barhoumi, T.C. Sewall, and J.A. Bowen Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43 J. Membr. Biol. 148 1995 243 253
8. 2+ mobilization Circ. Res. 81 1997 885 892
9. M. Chanson, M.M. White, and S.S. Garber cAMP promotes gap junctional coupling in T84 cells Am. J. Physiol., Cell Physiol. 271 1996 C533 C539
10. P. Colburn, and V. Buonassisi Estrogen binding sites in endothelial cell cultures Science 201 1978 817 819
11. K.P. Conrad, G.M. Joffe, H. Kruszyna, R. Kruszyna, L.G. Rochelle, R.P. Smith, J.E. Chavez, and M.D. Mosher Identification of increased nitric oxide biosynthesis during pregnancy in rats FASEB J. 7 1993 566 571
12. E. Enmark, and J.A. Gustafsson Oestrogen receptors-an overview J. Intern. Med. 246 1999 133 138
13. F.M. Faraci, and C.D. Sigmund Vascular biology in genetically altered mice: smaller vessels, bigger insight Circ. Res. 85 1999 1214 1225
14. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
15. S.J. Gladwell, and J.G. Jefferys Second messenger modulation of electrotonic coupling between region CA3 pyramidal cell axons in the rat hippocampus Neurosci. Lett. 300 2001 1 4
16. S.P. Glasser, A.P. Selwyn, and P. Granz Atherosclerosis: risk factors and vascular endothelium Am. Heart J. 131 1995 379 384
17. G.A. Gray, I. Sharif, D.J. Webb, and J.R. Seckl Oestrogen and the cardiovascular system: the good, the bad and the puzzling Trends Pharmacol. Sci. 22 2001 152 156
18. A.T. Grazul-Bilska, L.P. Reynolds, J.J. Bilski, and D.A. Redmer Effects of second messengers on gap junctional intercellular communication of ovine luteal cells throughout the estrous cycle Biol. Reprod. 65 2001 777 783
19. D.R. Harder, and P.B. Coulson Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle J. Cell. Physiol. 100 1979 375 382
20. T. Hayashi, J.M. Fukuto, L.J. Ignarro, and G. Chaudhuri Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 89 1992 11259 11263
21. T. Hayashi, K. Yamada, T. Esaki, M. Kuzuya, S. Satake, T. Ishikawa, H. Hidaka, and A. Iguchi Estrogen increases endothelial nitric oxide by a receptor-mediated system Biochem. Biophys. Res. Commun. 214 1995 847 855
22. C.S. Hayward, R.P. Kelly, and P. Collins The role of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc. Res. 46 2000 28 49
23. K. Hishikawa, T. Nakaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells FEBS Lett. 360 1995 291 293
24. P.L. Huang, Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
25. S. Hulley for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
26. L.J. Ignarro, R.G. Harbison, K.S. Wood, M.S. Wolin, D.B. McNamara, A.L. Hyman, and P.J. Kadowitz Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanisms of arterial relaxation involves cyclic guanosine 3′:5′-monophosphate and cyclic adenosine 3′:5′-monophosphate J. Pharmacol. Exp. Ther. 233 1985 560 569
27. K. Kamata, F. Umeda, and Y. Kasuya Possible existence of novel endothelium-derived relaxing factor in the endothelium of rat mesenteric arterial bed J. Cardiovasc. Pharmacol. 27 1996 601 606
28. R.H. Karas, B.L. Patterson, and M.E. Mendelsohn Human vascular smooth muscle cells contain functional estrogen receptor Circulation 89 1994 1943 1950
29. S.A. Kharitonov, R.B. Logan-Sinclair, C.M. Busset, and E.A. Shinebourne Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle Br. Heart J. 72 1994 243 245
30. W.R. Kukovetz, S. Holzmann, A. Wurm, and G. Poch Prostacyclin increases cAMP in coronary arteries J. Cycl. Nucleotide Res. 5 1979 469 476
31. R.L. Lantin-Hermoso, C.R. Rosenfeld, I.S. Yuhanna, Z. German, Z. Chen, and P.W. Shaul Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium Am. J. Physiol., Lung Cell Mol. Physiol. 273 1997 L119 L126
32. D.W. Losordo, M. Kearney, E.A. Kim, J. Jekanowski, and J.M. Isner Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of postmenopausal women Circulation 89 1994 1501 1510
33. T. Matoba, H. Shimokawa, M. Nakashima, Y. Hirakawa, Y. Mukai, K. Hirano, H. Kanaide, and A. Takeshita Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice J. Clin. Invest. 106 2000 1521 1530
34. T. Matoba, H. Shimokawa, H. Kubota, K. Morikawa, T. Fujiki, I. Kunihiro, Y. Mukai, Y. Hirakawa, and A. Takeshita Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries Biochem. Biophys. Res. Commun. 290 2002 909 913
35. J.A. McCrohn, W.A.W. Walters, J.T.C. Robinson, R.J. McCredie, L. Turner, M.R. Adams, D.J. Handersman, and D.S. Celermajer Arterial reactivity is enhanced in genetic males taking high dose estrogens J. Am. Coll. Cardiol. 29 1997 1432 1436
36. M.E. Mendelsohn, and R.H. Karas Mechanisms of disease: the protective effects of estrogen on the cardiovascular system N. Engl. J. Med. 340 1999 1801 1811
37. V.T. Miller, R.A. Muesing, J.C. LaRosa, D.B. Stoy, S.E. Fowler, and R.J. Stillman Quantitative and qualitative changes in lipids, lipoproteins, Apoprotein A-1, and sex hormone-binding globulin due to two doses of conjugated equine estrogen with and without a progestin Obstet. Gynecol. 83 1994 173 179
38. 2+ currents in aortic smooth muscle cells Eur. J. Pharmacol. 294 1995 625 635
39. 2+ channels through GTP-binding protein Br. J. Pharmacol. 117 1996 351 359
40. A.F. Paulson, P.D. Lampe, R.A. Meyer, E. Tenbroek, M.M. Atkinson, T.F. Walseth, and R.G. Johnson Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking J. Cell Sci. 113 2000 3037 3049
41. 2 Br. J. Pharmacol. 138 2003 1215 1220
42. D. Regoli Pharmacology of nitric oxide: molecular mechanisms and therapeutic strategies Curr. Pharm. Des. 10 2004 1667 1676
43. W.I. Rosenblum Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles Stroke 17 1986 494 497
44. + is the non-nitric oxide, non-prostanoid endothelium-derived relaxing factor in rat femoral arteries Vasc. Pharmacol. 40 2003 23 28
45. J.A. Staessen, H. Celis, and R. Fagard The epidemiology of the association between hypertension and menopause J. Hum. Hypertens. 12 1998 587 592
46. M.J. Stampfer, G.A. Colditz, W.C. Willet, J.E. Manson, B. Rosner, F.E. Speizer, and C.H. Hennekens Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurse's health study N. Engl. J. Med. 325 1991 756 762
47. H.J. Taylor, A.T. Chaytor, D.H. Edwards, and T.M. Griffith Gap junction-dependent increases in smooth muscle cAMP underpin the EDHF phenomenon in rabbit arteries Biochem. Biophys. Res. Commun. 283 2001 583 589
48. The Women's Health Initiative Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy JAMA 291 2004 1701 1712
49. R.C. Tostes, D. Nigro, Z.B. Fortes, and M.H.C. Carvalho Effects of estrogen on the vascular system Braz. J. Med. Biol. Res. 36 2003 1143 1158
50. M.G. Tudor Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br. J. Pharmacol. 141 2004 881 903
51. H.V. Van Rijen, T.A. van Veen, M.M. Hermans, and H.J. Jongsma Human connexin40 gap junction channels are modulated by cAMP Cardiovasc. Res. 45 2000 941 951
52. R.C. Venema, K. Nishida, R.W. Alexander, D.G. Harrison, and T.J. Murphy Organization of the bovine gene encoding the endothelial nitric oxide synthase Biochem. Biophys. Acta 1218 1994 413 420
53. A.H. Wagner, M.R. Schroeter, and M. Hecker 17 beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells FASEB J. 15 2001 2121 2130
54. C.P. Weiner, I. Lizasoain, S.A. Baylis, R.G. Knowles, I.G. Charles, and S. Moncada Induction of calcium-dependent nitric oxide synthases by sex hormones Proc. Natl. Acad. Sci. U. S. A. 91 1994 5212 5216
55. P.W. Wennberg, V.M. Miller, T. Rabelink, and J.C. Burnett Jr. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism Am. J. Physiol., Heart Circ. Physiol. 277 1999 H1618 H1621
56. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women JAMA 288 2002 321 333